Kadcyla

Active Ingredient(s): Ado-Trastuzumab Emtansine
FDA Approved: * February 22, 2013
Pharm Company: * GENENTECH
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Kadcyla Overview

Trastuzumab emtansine[1][2] also known as ado-trastuzumab emtansine and sold under the trade name Kadcyla, is an antibody-drug conjugate consisting of the humanized monoclonal antibody trastuzumab (Herceptin) covalently linked to the cytotoxic agent DM1.[3][4][5][6] Trastuzumab alone stops growth of cancer cells by binding to the HER2 receptor, whereas trastuzumab emtansine undergoes receptor-media...

Read more Kadcyla Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Trastuzumab_emtansine

Recent Kadcyla Forums: RSS Feed

high bilirubin

My mom received 2 doses of kadcyla. However her bilirubin count shot up to 2.98 & is unable to continue the treatment. Can u help? ## From what I've read, bilirubin is a yellowish pigment found in bile (a fluid made by the liver). Apparently, it is normal to have some bilirubin in your blood. However, normal levels are reportedly in the range of 0.3 to 1.9 mg/dL The article below discusses various tests that are done to measure the amount of bilirubin in the blood (and what it means to have high levels of it): nlm.nih.gov/medlineplus/ency/article/003479.htm In some patients, different types of cancer medication (such as kadcyla) could just end up doing more harm than good. So I would probably look at it as a good thing and not get discouraged by the discontinuation of the drug. ...

Updated

Possible Dosages for this and Related Drugs:

Ado-Trastuzumab Emtansine
  • Vial: 100mg, 160mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Kadcyla: (2 results)

Sorted by National Drug Code
  • 50242-087 Kadcyla 20 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Genentech, Inc.
  • 50242-088 Kadcyla 20 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Genentech, Inc.

Other drugs which contain Ado-Trastuzumab Emtansine or a similar ingredient: (2 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 25 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA